Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.

Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page's revision/update version was bumped from v3.6.2 to v3.6.3, indicating a new system update applied to the ClinicalTrials.gov record. This update reflects backend or UI improvements rather than changes to the study data or displayed information.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2. This indicates a new page build.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now displays a recruitment-closed notice and adds new user guidance sections to help readers understand and join studies. The Intervention/Treatment header formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag updates from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check40 days agoChange DetectedThe page's revision label was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer build of the page.SummaryDifference0.0%

- Check61 days agoChange DetectedA new footer revision label, Revision: v3.5.4, was added, and the old footer label Revision: v3.5.3 along with Related Info, AbbVie, and Helpful Links Provided by were removed, affecting non-critical navigation and metadata on the page.SummaryDifference0.2%

- Check75 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a new version of the page rendering. This change represents an update to the site's software or documentation rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.